High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients

被引:52
|
作者
Shafer, RW
Hertogs, K
Zolopa, AR
Warford, A
Bloor, S
Betts, BJ
Merigan, TC
Harrigan, R
Larder, BA
机构
[1] Stanford Univ, Med Ctr, Div Infect Dis, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, AIDS Res Ctr, Stanford, CA 94305 USA
[3] Stanford Univ Hosp, Diagnost Virol Lab, Stanford, CA 94305 USA
[4] Stanford Univ Hosp, Dept Biostat, Stanford, CA 94305 USA
[5] VIRCO Belgium, Cent Virol Lab, Mechelen, Belgium
[6] VIRCO UK, Cambridge CB4 4GH, England
关键词
D O I
10.1128/JCM.39.4.1522-1529.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We assessed the reproducibility of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) and protease sequencing using cryopreserved plasma aliquots obtained from 36 heavily treated HIV-1-infected individuals in two laboratories using: dideoxynucleotide sequencing. The rates of complete sequence concordance between the two laboratories were 99.1% for the protease sequence and 99.0% for the RT sequence. Approximately 90% of the discordances were partial, defined as one laboratory detecting a mixture and the second laboratory detecting only one of the mixture's components. Only 0.1% of the nucleotides were completely discordant between the two laboratories, and these were significantly more likely to occur in plasma samples with lower plasma HIV-I RNA levels, Nucleotide mixtures were detected at approximately 1% of the nucleotide positions, and in every case in which one laboratory detected a mixture, the second laboratory either detected the same mixture or detected one of the mixture's components. The high rate of concordance in detecting mixtures and the fact that most discordances between the two laboratories were partial suggest that most discordances were caused by variation in sampling of the HIV-1 quasispecies by PCR rather than by technical errors in the sequencing process itself.
引用
收藏
页码:1522 / 1529
页数:8
相关论文
共 50 条
  • [41] Topoisomerase I dissociates human immunodeficiency virus type 1 reverse transcriptase from genomic RNAs
    Takahashi, H
    Sawa, H
    Hasegawa, H
    Nagashima, K
    Sata, T
    Kurata, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 313 (04) : 1073 - 1078
  • [42] Characterization of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate
    QuinonesMateu, ME
    Soriano, V
    Domingo, E
    MenendezArias, L
    VIROLOGY, 1997, 236 (02) : 364 - 373
  • [43] Inhibition of human immunodeficiency virus type 1 reverse transcriptase by degradation products of ceftazidime
    Baertschi, SW
    Cantrell, AS
    Kuhfeld, MT
    Lorenz, LJ
    Boyd, DB
    Jaskunas, SR
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (04): : 353 - 362
  • [44] Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats
    Chang, M
    Sood, VK
    Wilson, GJ
    Kloosterman, DA
    Sanders, PE
    Hauer, MJ
    Fagerness, PE
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (02) : 228 - 242
  • [45] Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase
    Isaguliants, MG
    Pokrovskaya, K
    Kashuba, VI
    Pokholok, D
    Hinkula, J
    Wahren, B
    Kochetkov, SN
    FEBS LETTERS, 1999, 447 (2-3) : 232 - 236
  • [46] Effect of manuka honey on human immunodeficiency virus type 1 reverse transcriptase activity
    Obossou, Etienne Kochole
    Shikamoto, Yasuo
    Hoshino, Yuki
    Kohno, Hayato
    Ishibasi, Yukiko
    Kozasa, Tohru
    Taguchi, Maho
    Sakakibara, Iwao
    Tonooka, Keiko
    Shinozuka, Tatsuo
    Mori, Kazuya
    NATURAL PRODUCT RESEARCH, 2022, 36 (06) : 1552 - 1557
  • [47] Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients
    Shafer, RW
    Winters, MA
    Palmer, S
    Merigan, TC
    ANNALS OF INTERNAL MEDICINE, 1998, 128 (11) : 906 - 911
  • [48] Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations - Reply
    Young, B
    Kuritzkes, DR
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02): : 570 - 571
  • [49] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE AND RIBONUCLEASE-H AS SUBSTRATES OF THE VIRAL PROTEASE
    TOMASSELLI, AG
    SARCICH, JL
    BARRETT, LJ
    REARDON, IM
    HOWE, WJ
    EVANS, DB
    SHARMA, SK
    HEINRIKSON, RL
    PROTEIN SCIENCE, 1993, 2 (12) : 2167 - 2176
  • [50] PROCESSING PROTEASE AND REVERSE-TRANSCRIPTASE FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE-I POLYPROTEIN IN ESCHERICHIA-COLI
    MOUS, J
    HEIMER, EP
    LEGRICE, SFJ
    JOURNAL OF VIROLOGY, 1988, 62 (04) : 1433 - 1436